Anthem Biosciences, a Contract research, Development, and Manufacturing Organisation (CRDMO), is significantly expanding its manufacturing footprint. The move is driven by rising global demand for fermentation-based active pharmaceutical ingredients (APIs) and high-complexity custom synthesis projects.
Third Facility Goes Live; Fourth in the Pipeline
Anthem recently made its third manufacturing unit fully operational. This facility focuses on peptides and fermentation-based API production, reinforcing the company’s strength in niche, value-added segments.
At the same time, a fourth, large-scale facility is under development. Spanning 30 acres, unit four will be larger than units one, two, and three combined. The plant is expected to be fully operational within two years, significantly boosting production capacity.
Investment and Infrastructure Growth
To support this expansion, Anthem has invested ₹600 crore in unit three alone. The company’s total gross block now exceeds ₹1,300 crore, with an additional ₹300 crore allocated to capital work-in-progress, reflecting its long-term growth strategy.
Export-Driven Growth Model
With over 80% of its revenue generated from exports, Anthem primarily serves customers in the US, Europe, and China. The company positions itself as a strategic partner to global innovators across both pharmaceutical and wellness sectors.
Focus on Novel, High-Margin Products
Anthem’s business model emphasizes innovation and margin-rich offerings. It specializes in fermentation-based APIs, including:
*Probiotics
*Enzymes
*Peptides
*Vitamins
The company works directly with innovator firms, often supplying advanced intermediates and APIs that feature in New Drug Applications (NDAs) filed by its global clients.
Strengthening Position in the Global CRDMO Landscape
With its expanding infrastructure, robust export orientation, and focus on high-value biopharma products, Anthem Biosciences is consolidating its role as a trusted partner to international drug developers. As reported by business-standard.com, the ongoing expansion signals Anthem’s commitment to delivering advanced manufacturing solutions at scale.
